GAIN THERAPEUTICS, INC Deferred Income, Noncurrent
GAIN THERAPEUTICS, INC (GANX) had Deferred Income, Noncurrent of $47.44 thousand as of 2024-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DeferredIncomeNoncurrent · last filed 2026-03-26
- 2024-12-31: Deferred Income, Noncurrent $47.44K.
- 2024-09-30: Deferred Income, Noncurrent $65.87K.
- 2024-06-30: Deferred Income, Noncurrent $80.36K.
- 2024-03-31: Deferred Income, Noncurrent $64.30K.
| Period end | Deferred Income, Noncurrent |
|---|---|
| 2024-12-31 | $47.44K 10-K · filed 2026-03-26 |
| 2024-09-30 | $65.87K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $80.36K 10-Q · filed 2024-08-08 |
| 2024-03-31 | $64.30K 10-Q · filed 2024-05-14 |
| 2023-12-31 | $94.79K 10-K · filed 2025-03-27 |
| 2023-09-30 | $144.34K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $608.98K 10-Q · filed 2023-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B |